News Focus
News Focus
icon url

Det_Robert_Thorne

04/12/17 3:17 PM

#71986 RE: Gailm #71984

I have low expectations for 2016 results

Unless there is some revenue from stock received in 4Q/16, I expect something like the following in HEMP's FY2016 Annual Pink Sheet Basic Report and Disclosure (Not an audited 10-K, because HEMP isn't an SEC-registered stock):

* 2016 Revenue of $750K - $775K. About $720K of this will be the value of the stock received from FUTL and GRCU in 1Q/16 for "consulting" contracts. IIRC, GRCU cancelled its relationship with HEMP when the SEC action against Perlowin and HEMP was announced. Therefore, HEMP's revenue from product sales will only be $30K - $75K.

* A 2016 net loss of $16.5M - $17.5M, with $15M-$16M of that being stock-based compensation

* The OS will end the year at 12.3B - 12.7B shares. That will be an increase of 775M - 812M shares from the end of 2015, with nearly half of that increase occurring in 4Q/16.

* The filing will also show that a good amount of the share subscriptions (mostly owned by Perlowin) will have been converted to Preferred K shares, but also that someone (again, likely Bruce) will have lent more cash to HEMP in 4Q/16, and that loan was converted to a share subscription at the end of the quarter.

P.S.: I realized today that my HEMP spreadsheet doesn't have a quarter-by-quarter record of HEMP's Statement of Operations (Rev, expenses and Net Profit/loss), so I'll try to create one and populate it with info from 2014 - 2016 ASAP.